Human epidermal growth factor receptor 2 (Her2)-positive breast cancer, which is one of many breast cancer subtypes, has attracted much attention because of its strong invasiveness, poor tumor-free survival, and poor overall survival (OS) rate [1–3]. Here, ERBB2 is linked to neoplasm.